Switch to:
Also traded in: Germany, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.61
EMR's Cash-to-Debt is ranked lower than
61% of the 1872 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.05 vs. EMR: 0.61 )
Ranked among companies with meaningful Cash-to-Debt only.
EMR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.17 Max: 1.24
Current: 0.61
0.06
1.24
Equity-to-Asset 0.41
EMR's Equity-to-Asset is ranked lower than
69% of the 1837 Companies
in the Global Diversified Industrials industry.

( Industry Median: 0.53 vs. EMR: 0.41 )
Ranked among companies with meaningful Equity-to-Asset only.
EMR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.35  Med: 0.44 Max: 0.57
Current: 0.41
0.35
0.57
Debt-to-Equity 0.65
EMR's Debt-to-Equity is ranked lower than
69% of the 1470 Companies
in the Global Diversified Industrials industry.

( Industry Median: 0.38 vs. EMR: 0.65 )
Ranked among companies with meaningful Debt-to-Equity only.
EMR' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.24  Med: 0.53 Max: 1
Current: 0.65
0.24
1
Debt-to-EBITDA 1.64
EMR's Debt-to-EBITDA is ranked higher than
60% of the 1450 Companies
in the Global Diversified Industrials industry.

( Industry Median: 2.24 vs. EMR: 1.64 )
Ranked among companies with meaningful Debt-to-EBITDA only.
EMR' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.94  Med: 1.3 Max: 2.15
Current: 1.64
0.94
2.15
Interest Coverage 12.95
EMR's Interest Coverage is ranked lower than
65% of the 1611 Companies
in the Global Diversified Industrials industry.

( Industry Median: 37.14 vs. EMR: 12.95 )
Ranked among companies with meaningful Interest Coverage only.
EMR' s Interest Coverage Range Over the Past 10 Years
Min: 12.95  Med: 15.81 Max: 18.39
Current: 12.95
12.95
18.39
Piotroski F-Score: 6
Altman Z-Score: 5.17
Beneish M-Score: -2.53
WACC vs ROIC
8.92%
21.26%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 19.22
EMR's Operating Margin % is ranked higher than
91% of the 1861 Companies
in the Global Diversified Industrials industry.

( Industry Median: 6.26 vs. EMR: 19.22 )
Ranked among companies with meaningful Operating Margin % only.
EMR' s Operating Margin % Range Over the Past 10 Years
Min: 15.23  Med: 17.46 Max: 20.29
Current: 19.22
15.23
20.29
Net Margin % 9.84
EMR's Net Margin % is ranked higher than
78% of the 1860 Companies
in the Global Diversified Industrials industry.

( Industry Median: 4.58 vs. EMR: 9.84 )
Ranked among companies with meaningful Net Margin % only.
EMR' s Net Margin % Range Over the Past 10 Years
Min: 8.06  Med: 9.98 Max: 16.68
Current: 9.84
8.06
16.68
ROE % 18.54
EMR's ROE % is ranked higher than
85% of the 1819 Companies
in the Global Diversified Industrials industry.

( Industry Median: 7.12 vs. EMR: 18.54 )
Ranked among companies with meaningful ROE % only.
EMR' s ROE % Range Over the Past 10 Years
Min: 18.54  Med: 22.25 Max: 29.78
Current: 18.54
18.54
29.78
ROA % 7.41
EMR's ROA % is ranked higher than
77% of the 1880 Companies
in the Global Diversified Industrials industry.

( Industry Median: 3.71 vs. EMR: 7.41 )
Ranked among companies with meaningful ROA % only.
EMR' s ROA % Range Over the Past 10 Years
Min: 7.41  Med: 9.47 Max: 11.85
Current: 7.41
7.41
11.85
ROC (Joel Greenblatt) % 58.93
EMR's ROC (Joel Greenblatt) % is ranked higher than
93% of the 1875 Companies
in the Global Diversified Industrials industry.

( Industry Median: 12.63 vs. EMR: 58.93 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
EMR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 48.89  Med: 62.74 Max: 78.87
Current: 58.93
48.89
78.87
3-Year Revenue Growth Rate -13.00
EMR's 3-Year Revenue Growth Rate is ranked lower than
86% of the 1738 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.60 vs. EMR: -13.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
EMR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -13  Med: 5.5 Max: 15
Current: -13
-13
15
3-Year EBITDA Growth Rate -6.70
EMR's 3-Year EBITDA Growth Rate is ranked lower than
75% of the 1552 Companies
in the Global Diversified Industrials industry.

( Industry Median: 5.30 vs. EMR: -6.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
EMR' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -10.7  Med: 7.5 Max: 18
Current: -6.7
-10.7
18
3-Year EPS without NRI Growth Rate -3.90
EMR's 3-Year EPS without NRI Growth Rate is ranked lower than
63% of the 1423 Companies
in the Global Diversified Industrials industry.

( Industry Median: 4.70 vs. EMR: -3.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
EMR' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -9.9  Med: 7 Max: 22.8
Current: -3.9
-9.9
22.8
GuruFocus has detected 6 Warning Signs with Emerson Electric Co EMR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» EMR's 30-Y Financials

Financials (Next Earnings Date: 2017-11-07)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

EMR Guru Trades in Q4 2016

Ken Fisher 4,278 sh (New)
Steven Cohen 105,000 sh (New)
Jim Simons 1,591,900 sh (New)
Stanley Druckenmiller 175,000 sh (New)
Paul Tudor Jones 23,637 sh (+46.35%)
Manning & Napier Advisors, Inc 102,638 sh (+3.96%)
David Dreman Sold Out
Tom Gayner Sold Out
Barrow, Hanley, Mewhinney & Strauss Sold Out
Ray Dalio Sold Out
Charles Brandes 2,523,236 sh (-3.15%)
Arnold Van Den Berg 173,910 sh (-3.68%)
Murray Stahl 26,062 sh (-4.40%)
Jeremy Grantham 3,907,037 sh (-6.23%)
T Rowe Price Equity Income Fund 3,930,000 sh (-7.53%)
Joel Greenblatt 988,116 sh (-9.19%)
Mairs and Power 1,856,185 sh (-14.73%)
Tweedy Browne 1,387,802 sh (-18.74%)
Charles de Vaulx 557,158 sh (-24.01%)
Chuck Royce 21,500 sh (-40.28%)
Andreas Halvorsen 295,425 sh (-74.24%)
» More
Q1 2017

EMR Guru Trades in Q1 2017

George Soros 4,600 sh (New)
Ray Dalio 5,867 sh (New)
Steven Cohen 479,700 sh (+356.86%)
Chuck Royce 43,600 sh (+102.79%)
Manning & Napier Advisors, Inc 105,986 sh (+3.26%)
Charles de Vaulx 557,158 sh (unchged)
Ken Fisher Sold Out
Andreas Halvorsen Sold Out
Stanley Druckenmiller Sold Out
Murray Stahl 25,287 sh (-2.97%)
Arnold Van Den Berg 167,580 sh (-3.64%)
Tweedy Browne 1,330,159 sh (-4.15%)
Charles Brandes 2,391,767 sh (-5.21%)
T Rowe Price Equity Income Fund 3,600,000 sh (-8.40%)
Jeremy Grantham 3,552,891 sh (-9.06%)
Joel Greenblatt 888,475 sh (-10.08%)
Jim Simons 1,257,000 sh (-21.04%)
Mairs and Power 1,352,162 sh (-27.15%)
Paul Tudor Jones 10,310 sh (-56.38%)
» More
Q2 2017

EMR Guru Trades in Q2 2017

Manning & Napier Advisors, Inc 137,569 sh (+29.80%)
Paul Tudor Jones 12,686 sh (+23.05%)
Chuck Royce 48,000 sh (+10.09%)
Joel Greenblatt 901,491 sh (+1.46%)
Charles de Vaulx 557,158 sh (unchged)
Ray Dalio Sold Out
Jim Simons Sold Out
T Rowe Price Equity Income Fund 3,595,400 sh (-0.13%)
Jeremy Grantham 3,436,646 sh (-3.27%)
Murray Stahl 24,262 sh (-4.05%)
George Soros 4,400 sh (-4.35%)
Arnold Van Den Berg 160,202 sh (-4.40%)
Tweedy Browne 1,254,929 sh (-5.66%)
Charles Brandes 1,919,432 sh (-19.75%)
Steven Cohen 353,427 sh (-26.32%)
Mairs and Power 764,484 sh (-43.46%)
» More
Q3 2017

EMR Guru Trades in Q3 2017

T Rowe Price Equity Income Fund 3,350,000 sh (-6.83%)
» More
» Details

Insider Trades

Latest Guru Trades with EMR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
T Rowe Price Equity Income Fund 2017-09-30 Reduce -6.83%0.07%$58 - $63.89 $ 66.1010%3,350,000
T Rowe Price Equity Income Fund 2017-06-30 Reduce -0.13%$57.44 - $61.38 $ 66.1011%3,595,400
Charles Brandes 2017-06-30 Reduce -19.75%0.42%$57.44 - $61.38 $ 66.1012%1,919,432
Tweedy Browne 2017-06-30 Reduce -5.66%0.13%$57.44 - $61.38 $ 66.1012%1,254,929
Joel Greenblatt 2017-06-30 Add 1.46%0.01%$57.44 - $61.38 $ 66.1012%901,491
Arnold Van Den Berg 2017-06-30 Reduce -4.40%0.07%$57.44 - $61.38 $ 66.1012%160,202
George Soros 2017-06-30 Reduce -4.35%$57.44 - $61.38 $ 66.1012%4,400
T Rowe Price Equity Income Fund 2017-03-31 Reduce -8.40%0.08%$56.14 - $64.15 $ 66.1011%3,600,000
Charles Brandes 2017-03-31 Reduce -5.21%0.11%$56.14 - $64.15 $ 66.1011%2,391,767
Tweedy Browne 2017-03-31 Reduce -4.15%0.1%$56.14 - $64.15 $ 66.1011%1,330,159
Joel Greenblatt 2017-03-31 Reduce -10.08%0.07%$56.14 - $64.15 $ 66.1011%888,475
Arnold Van Den Berg 2017-03-31 Reduce -3.64%0.06%$56.14 - $64.15 $ 66.1011%167,580
George Soros 2017-03-31 New Buy0.01%$56.14 - $64.15 $ 66.1011%4,600
Ken Fisher 2017-03-31 Sold Out $56.14 - $64.15 $ 66.1011%0
T Rowe Price Equity Income Fund 2016-12-31 Reduce -7.53%0.08%$49.41 - $58.26 $ 66.1023%3,930,000
Charles Brandes 2016-12-31 Reduce -3.15%0.07%$49.41 - $58.26 $ 66.1023%2,523,236
Tweedy Browne 2016-12-31 Reduce -18.74%0.52%$49.41 - $58.26 $ 66.1023%1,387,802
Joel Greenblatt 2016-12-31 Reduce -9.19%0.07%$49.41 - $58.26 $ 66.1023%988,116
Arnold Van Den Berg 2016-12-31 Reduce -3.68%0.06%$49.41 - $58.26 $ 66.1023%173,910
Ken Fisher 2016-12-31 New Buy$49.41 - $58.26 $ 66.1023%4,278
Tom Gayner 2016-12-31 Sold Out 0.22%$49.41 - $58.26 $ 66.1023%0
David Dreman 2016-12-31 Sold Out 0.58%$49.41 - $58.26 $ 66.1023%0
Barrow, Hanley, Mewhinney & Strauss 2016-12-31 Sold Out 0.05%$49.41 - $58.26 $ 66.1023%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Industrial Products » Diversified Industrials    NAICS: 335999    SIC: 3569
Compare:TSE:6954, XAMS:PHIA, TSE:6594, NYSE:ETN, XPAR:SU, OSTO:ATCO B, NYSE:ITW, XSWX:ABBN, NYSE:CMI, OHEL:KNEBV, NYSE:ROP, TSE:6273, NYSE:PH, XSWX:SCHN, NYSE:ROK, NYSE:IR, OSTO:SAND, XPAR:LR, OCSE:VWS, NYSE:AME » details
Traded in other countries:EMR.Germany, EMR.Mexico, EMR.Switzerland, 0R33.UK,
Headquarter Location:USA
Emerson Electric Co is engaged in designing and supplying products and technology, and delivering engineering services and solutions in industrial, commercial and consumer markets.

Emerson Electric recently divided its business operations into two segments: Automation Solutions and Commercial & Residential Solutions. The company specializes in large scale automation systems for process-oriented heavy industries, including oil and gas, refining, chemicals, and power. Automation products include sensors, valves, flow control, and final control, which can combine to remotely operate single to multisite systems. The company also manufactures air conditioning compressors, electric tools, and food disposal products.

Guru Investment Theses on Emerson Electric Co

IVA Funds Comments on Emerson - Sep 27, 2016

Question: You hold Emerson Electric. It's always acquired a lot of companies over the years. Do you think it could be anything like a Valeant, who acquired a lot of companies over the years, or have some characteristics like that?

Chuck de Lardemelle: No, not at all. Emerson (NYSE:EMR) has a very strong track record of making smart acquisitions, spending some Research and Development. Now, over the last few years, they've diversified into a business that they are now trying to spin off and making a number of acquisitions in uninterruptible power supplies/electronics. That vertical, if you will, has not worked out at all for Emerson, and they are going back to basics and spinning off or selling that division. The balance sheet is extremely strong, which is absolutely not the case of a Valeant.

Emerson is in no position to hike prices and gouge clients. It's a very strong industrial company that is extremely well managed from an operational point of view, that has a strong balance sheet, and has not been able to hike prices substantially. However, again, over the last few years, they've gathered a collection of companies in one segment and those acquisitions turned out to be a mistake. And that's what provided us with an opportunity to get into Emerson. And they recognized their mistake and are now trying to correct it. So, in no way, shape, or form is it similar to a Valeant, in our opinion.

From Charles de Vaulx (Trades, Portfolio)'s semi-annual 2016 IVA Funds call.

Check out Charles de Vaulx latest stock trades

Brandes Investment Trust Comments on Emerson Electric - Jan 06, 2016

Emerson Electric (NYSE:EMR) is another high-quality company with a strong competitive position, conservative balance sheet and attractive long-term returns on capital. Similar to Schneider’s case, over the last few years, the market has become concerned about Emerson’s exposure to emerging markets. Investors also seem worried about the cyclicality of its process automation business, particularly its high exposure to the oil & gas end market.



Despite the negative sentiment, we believe Emerson is well positioned to continue generating value in each of its business segments, which have attractive long-term growth prospects based on our analysis. While concerns surrounding Emerson’s oil & gas exposure and the cyclicality of the process automation business are warranted, we feel that its shares are overly discounted at the company’s current valuation.



From the Brandes Global Equity Fund letter for the year ended Sept. 30, 2015.



Check out Charles Brandes latest stock trades

Ratios

vs
industry
vs
history
PE Ratio 29.39
EMR's PE Ratio is ranked lower than
59% of the 1478 Companies
in the Global Diversified Industrials industry.

( Industry Median: 23.05 vs. EMR: 29.39 )
Ranked among companies with meaningful PE Ratio only.
EMR' s PE Ratio Range Over the Past 10 Years
Min: 9.07  Med: 18.7 Max: 30.51
Current: 29.39
9.07
30.51
Forward PE Ratio 22.68
EMR's Forward PE Ratio is ranked lower than
66% of the 167 Companies
in the Global Diversified Industrials industry.

( Industry Median: 18.98 vs. EMR: 22.68 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 26.33
EMR's PE Ratio without NRI is ranked lower than
54% of the 1482 Companies
in the Global Diversified Industrials industry.

( Industry Median: 23.00 vs. EMR: 26.33 )
Ranked among companies with meaningful PE Ratio without NRI only.
EMR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.77  Med: 18.99 Max: 30.51
Current: 26.33
8.77
30.51
Price-to-Owner-Earnings 23.77
EMR's Price-to-Owner-Earnings is ranked higher than
50% of the 883 Companies
in the Global Diversified Industrials industry.

( Industry Median: 22.57 vs. EMR: 23.77 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
EMR' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.17  Med: 16.31 Max: 24.58
Current: 23.77
8.17
24.58
PB Ratio 5.30
EMR's PB Ratio is ranked lower than
84% of the 1820 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.94 vs. EMR: 5.30 )
Ranked among companies with meaningful PB Ratio only.
EMR' s PB Ratio Range Over the Past 10 Years
Min: 2.3  Med: 4.18 Max: 5.32
Current: 5.3
2.3
5.32
PS Ratio 2.89
EMR's PS Ratio is ranked lower than
71% of the 1817 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.32 vs. EMR: 2.89 )
Ranked among companies with meaningful PS Ratio only.
EMR' s PS Ratio Range Over the Past 10 Years
Min: 0.82  Med: 1.85 Max: 3.52
Current: 2.89
0.82
3.52
Price-to-Free-Cash-Flow 27.16
EMR's Price-to-Free-Cash-Flow is ranked lower than
65% of the 633 Companies
in the Global Diversified Industrials industry.

( Industry Median: 19.42 vs. EMR: 27.16 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
EMR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.49  Med: 15.34 Max: 27.28
Current: 27.16
8.49
27.28
Price-to-Operating-Cash-Flow 21.14
EMR's Price-to-Operating-Cash-Flow is ranked lower than
71% of the 792 Companies
in the Global Diversified Industrials industry.

( Industry Median: 13.12 vs. EMR: 21.14 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
EMR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.58  Med: 12.29 Max: 21.25
Current: 21.14
6.58
21.25
EV-to-EBIT 17.44
EMR's EV-to-EBIT is ranked higher than
51% of the 1537 Companies
in the Global Diversified Industrials industry.

( Industry Median: 16.85 vs. EMR: 17.44 )
Ranked among companies with meaningful EV-to-EBIT only.
EMR' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.5  Med: 12.9 Max: 17.53
Current: 17.44
6.5
17.53
EV-to-EBITDA 14.11
EMR's EV-to-EBITDA is ranked lower than
52% of the 1607 Companies
in the Global Diversified Industrials industry.

( Industry Median: 12.77 vs. EMR: 14.11 )
Ranked among companies with meaningful EV-to-EBITDA only.
EMR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 10.6 Max: 14.19
Current: 14.11
5.5
14.19
EV-to-Revenue 3.01
EMR's EV-to-Revenue is ranked lower than
72% of the 1836 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.40 vs. EMR: 3.01 )
Ranked among companies with meaningful EV-to-Revenue only.
EMR' s EV-to-Revenue Range Over the Past 10 Years
Min: 1  Med: 2 Max: 3.9
Current: 3.01
1
3.9
Shiller PE Ratio 21.27
EMR's Shiller PE Ratio is ranked higher than
67% of the 409 Companies
in the Global Diversified Industrials industry.

( Industry Median: 28.39 vs. EMR: 21.27 )
Ranked among companies with meaningful Shiller PE Ratio only.
EMR' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.32  Med: 21.24 Max: 33.15
Current: 21.27
13.32
33.15
Current Ratio 1.59
EMR's Current Ratio is ranked lower than
61% of the 1747 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.86 vs. EMR: 1.59 )
Ranked among companies with meaningful Current Ratio only.
EMR' s Current Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.37 Max: 2.5
Current: 1.59
0.93
2.5
Quick Ratio 1.24
EMR's Quick Ratio is ranked lower than
54% of the 1745 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.32 vs. EMR: 1.24 )
Ranked among companies with meaningful Quick Ratio only.
EMR' s Quick Ratio Range Over the Past 10 Years
Min: 0.59  Med: 0.95 Max: 2.15
Current: 1.24
0.59
2.15
Days Inventory 66.16
EMR's Days Inventory is ranked higher than
69% of the 1808 Companies
in the Global Diversified Industrials industry.

( Industry Median: 98.05 vs. EMR: 66.16 )
Ranked among companies with meaningful Days Inventory only.
EMR' s Days Inventory Range Over the Past 10 Years
Min: 49.85  Med: 55.75 Max: 72.33
Current: 66.16
49.85
72.33
Days Sales Outstanding 72.35
EMR's Days Sales Outstanding is ranked higher than
58% of the 1453 Companies
in the Global Diversified Industrials industry.

( Industry Median: 80.49 vs. EMR: 72.35 )
Ranked among companies with meaningful Days Sales Outstanding only.
EMR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 64.47  Med: 68.58 Max: 103.31
Current: 72.35
64.47
103.31
Days Payable 69.69
EMR's Days Payable is ranked higher than
53% of the 1408 Companies
in the Global Diversified Industrials industry.

( Industry Median: 65.99 vs. EMR: 69.69 )
Ranked among companies with meaningful Days Payable only.
EMR' s Days Payable Range Over the Past 10 Years
Min: 56.72  Med: 66.83 Max: 108.02
Current: 69.69
56.72
108.02

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.90
EMR's Dividend Yield % is ranked higher than
83% of the 1889 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.31 vs. EMR: 2.90 )
Ranked among companies with meaningful Dividend Yield % only.
EMR' s Dividend Yield % Range Over the Past 10 Years
Min: 1.84  Med: 2.91 Max: 5.01
Current: 2.9
1.84
5.01
Dividend Payout Ratio 0.76
EMR's Dividend Payout Ratio is ranked lower than
77% of the 1202 Companies
in the Global Diversified Industrials industry.

( Industry Median: 0.31 vs. EMR: 0.76 )
Ranked among companies with meaningful Dividend Payout Ratio only.
EMR' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.39  Med: 0.53 Max: 0.78
Current: 0.76
0.39
0.78
3-Year Dividend Growth Rate 5.00
EMR's 3-Year Dividend Growth Rate is ranked lower than
53% of the 910 Companies
in the Global Diversified Industrials industry.

( Industry Median: 6.30 vs. EMR: 5.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
EMR' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 1.5  Med: 7.6 Max: 14
Current: 5
1.5
14
Forward Dividend Yield % 2.92
EMR's Forward Dividend Yield % is ranked higher than
79% of the 1801 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.75 vs. EMR: 2.92 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.94
EMR's 5-Year Yield-on-Cost % is ranked higher than
80% of the 2315 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.99 vs. EMR: 3.94 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
EMR' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.5  Med: 3.95 Max: 6.8
Current: 3.94
2.5
6.8
3-Year Average Share Buyback Ratio 3.10
EMR's 3-Year Average Share Buyback Ratio is ranked higher than
95% of the 1066 Companies
in the Global Diversified Industrials industry.

( Industry Median: -2.20 vs. EMR: 3.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
EMR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -0.2  Med: 1.1 Max: 3.3
Current: 3.1
-0.2
3.3

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 52.88
EMR's Price-to-Tangible-Book is ranked lower than
99% of the 1722 Companies
in the Global Diversified Industrials industry.

( Industry Median: 2.13 vs. EMR: 52.88 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
EMR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.41  Med: 13.12 Max: 150.63
Current: 52.88
3.41
150.63
Price-to-Intrinsic-Value-Projected-FCF 1.45
EMR's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
58% of the 992 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.60 vs. EMR: 1.45 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
EMR' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.61  Med: 1.35 Max: 2.06
Current: 1.45
0.61
2.06
Price-to-Median-PS-Value 1.56
EMR's Price-to-Median-PS-Value is ranked lower than
66% of the 1629 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.24 vs. EMR: 1.56 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
EMR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.5  Med: 0.9 Max: 1.76
Current: 1.56
0.5
1.76
Price-to-Graham-Number 7.86
EMR's Price-to-Graham-Number is ranked lower than
96% of the 1272 Companies
in the Global Diversified Industrials industry.

( Industry Median: 1.60 vs. EMR: 7.86 )
Ranked among companies with meaningful Price-to-Graham-Number only.
EMR' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.37  Med: 3.54 Max: 10.06
Current: 7.86
1.37
10.06
Earnings Yield (Greenblatt) % 5.74
EMR's Earnings Yield (Greenblatt) % is ranked higher than
60% of the 1878 Companies
in the Global Diversified Industrials industry.

( Industry Median: 4.52 vs. EMR: 5.74 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
EMR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.72  Med: 7.8 Max: 15.3
Current: 5.74
5.72
15.3
Forward Rate of Return (Yacktman) % 1.46
EMR's Forward Rate of Return (Yacktman) % is ranked lower than
64% of the 1089 Companies
in the Global Diversified Industrials industry.

( Industry Median: 6.55 vs. EMR: 1.46 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
EMR' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1.46  Med: 10.6 Max: 26.5
Current: 1.46
1.46
26.5

More Statistics

Revenue (TTM) (Mil) $14,761.00
EPS (TTM) $ 2.25
Beta1.28
Short Percentage of Float1.43%
52-Week Range $49.38 - 66.10
Shares Outstanding (Mil)640.02

Analyst Estimate

Sep17 Sep18 Sep19
Revenue (Mil $) 15,271 16,706 17,630
EPS ($) 2.54 2.89 3.20
EPS without NRI ($) 2.54 2.89 3.20
EPS Growth Rate
(Future 3Y To 5Y Estimate)
8.63%
Dividends per Share ($) 1.92 2.00

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}